EICHORCondition: Acute Myeloid Leukemia · Relapse/Recurrence · Sponsor: Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
Sponsor, CRO or site team? See where this study is running → — listed sites, countries and recruiting context. Everything below is written for patients and caregivers.
This is a multicenter, randomized, open-label, pragmatic low intervention clinical trial comparing high intensity reinduction chemotherapy with low intensity therapies in 1st or 2nd relapse Acute Myeloid Leukemia. The study is funded by European Commission (HORIZON-MISS-2022-CANCER-01-03, Project ID 101104421)
This description comes directly from the study's public registry record.
Oriana Nanni · +39 0543739100 · cc.ubsc@irst.emr.it
Impact-aml coord Impact-aml coord · impact-aml@irst.emr.it
Always discuss trial participation with your own doctor first.
| University Hospital Brno | Brno, Czechia | Recruiting |
| University Hospital Hradec Králové | Hradec Králové, Czechia | Not Yet Recruiting |
| University Hospital Olomouc | Olomouc, Czechia | Not Yet Recruiting |
| University Hospital in Ostrava | Ostrava, Czechia | Not Yet Recruiting |
| University Hospital in Pilsen | Pilsen, Czechia | Recruiting |
| Uniklinik RWTH Aachen | Aachen, Germany | Recruiting |
| University Hospital Greifswald | Greifswald, Germany | Recruiting |
| Krankenhaus St. Elisabeth und St. Barbara Halle (Saale) GmbH | Halle, Germany | Recruiting |
| University Hospital Halle | Halle, Germany | Recruiting |
| University Hospital of Rostock | Rostock, Germany | Recruiting |
| Heinrich-Braun-Klinikum gGmbH | Zwickau, Germany | Recruiting |
| Policlinico Sant'Orsola | Bologna, BO, Italy | Recruiting |
+ 35 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06713837